Arsenic Binding to RBCC Domain Modulates Oncogenic PML-RARa and Wild-Type PML as a Key Molecular Mechanism of Arsenic Trioxide Treatment for APL

	Arsenic Binding to RBCC Domain Modulates Oncogenic PML-RARa and Wild-Type PML as a Key Molecular Mechanism of Arsenic Trioxide Treatment for APL
	Zhang, XW; Yan, XJ; Yang, FF; Zhou, ZR; Wu, ZY; Sun, HB; Liang, WX; Song, AX; Huang, QH; Zhou, GB
刊名	BLOOD
	2009
卷号	114 期号:22 页码:#REF!
学科主题	Hematology
类目[WOS]	Hematology
收录类别	SCI
WOS记录号	WOS:000272725800593
公开日期	2016-05-03
内容类型	期刊论文
源URL	[http://ir.ihep.ac.cn/handle/311005/227177]
专题	高能物理研究所_多学科研究中心
推荐引用方式 GB/T 7714	Zhang, XW,Yan, XJ,Yang, FF,et al. Arsenic Binding to RBCC Domain Modulates Oncogenic PML-RARa and Wild-Type PML as a Key Molecular Mechanism of Arsenic Trioxide Treatment for APL[J]. BLOOD,2009,114(22):#REF!.
APA	Zhang, XW.,Yan, XJ.,Yang, FF.,Zhou, ZR.,Wu, ZY.,...&吴自玉.(2009).Arsenic Binding to RBCC Domain Modulates Oncogenic PML-RARa and Wild-Type PML as a Key Molecular Mechanism of Arsenic Trioxide Treatment for APL.BLOOD,114(22),#REF!.
MLA	Zhang, XW,et al."Arsenic Binding to RBCC Domain Modulates Oncogenic PML-RARa and Wild-Type PML as a Key Molecular Mechanism of Arsenic Trioxide Treatment for APL".BLOOD 114.22(2009):#REF!.